Literature DB >> 24356372

Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.

Runmin Guo1, Keng Wu, Jingfu Chen, Liqiu Mo, Xiaoxiao Hua, Dongdan Zheng, Peixi Chen, Gang Chen, Wenming Xu, Jianqiang Feng.   

Abstract

BACKGROUND/AIM: We have demonstrated that exogenous hydrogen sulfide (H2S) protects H9c2 cardiac cells against the doxorubicin (DOX)-induced injuries by inhibiting p38 mitogen-activated protein kinase (MAPK) pathway and that the p38 MAPK/nuclear factor-κB (NF-κB) pathway is involved in the DOX-induced inflammatory response and cytotoxicity. The present study attempts to test the hypothesis that exogenous H2S might protect cardiomyocytes against the DOX-induced inflammation and cytotoxicity through inhibiting p38 MAPK/NF-κB pathway.
METHODS: H9c2 cardiac cells were exposed to 5μM DOX for 24 h to establish a model of DOX cardiotoxicity. The cells were pretreated with NaHS( a donor of H2S) or other drugs before exposure to DOX. Cell viability was analyzed by cell counter kit 8 ( CCK-8), The expression of NF-κB p65 and inducible nitric oxide synthase (iNOS) was detected by Western blot assay. The levels of interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) were tested by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Our findings demonstrated that pretreatment of H9c2 cardiac cells with NaHS for 30 min before exposure to DOX markedly ameliorated the DOX-induced phosphorylation and nuclear translocation of NF-κB p65 subunit. Importantly, the pretreatment with NaHS significantly attenuated the p38 MAPK/NF-κB pathway-mediated inflammatory responses induced by DOX, as evidenced by decreases in the levels of IL-1β, IL-6 and TNF-α. In addition, application of NaHS or IL-1β receptor antagonist (IL-1Ra) or PDTC (an inhibitor of NF-κB) attenuated the DOX-induced expression of iNOS and production of nitric oxide (NO), respectively. Furthermore, IL-1Ra also dramatically reduced the DOX-induced cytotoxicity and phosphorylation of NF-κB p65. The pretreatment of H9c2 cells with N-acetyl-L-cysteine (NAC), a scavenger of reactive oxygen species (ROS) prior to exposure to DOX depressed the phosphorylation of NF-κB p65 induced by DOX.
CONCLUSION: The present study has demonstrated the new mechanistic evidence that exogenous H2S attenuates the DOX-induced inflammation and cytotoxicity by inhibiting p38 MAPK/NF-κB pathway in H9c2 cardiac cells. We also provide novel data that the interaction between NF-κB pathway and IL-1β is important in the induction of DOX-induced inflammation and cytotoxicity in H9c2 cardiac cells.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24356372     DOI: 10.1159/000356602

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  28 in total

1.  Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer.

Authors:  Jing Wu; Xia Xue; Bin Zhang; Hongmei Cao; Feng Kong; Wen Jiang; Juan Li; Deqing Sun; Ruichen Guo
Journal:  Tumour Biol       Date:  2016-06-07

Review 2.  Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy.

Authors:  Sumit Kar; Tyler N Kambis; Paras K Mishra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 4.733

3.  Supramolecular nanostructures with tunable donor loading for controlled H2S release.

Authors:  Yin Wang; John B Matson
Journal:  ACS Appl Bio Mater       Date:  2019-10-16

4.  Effects of CCK-8 and Cystathionine γ-Lyase/Hydrogen Sulfide System on Acute Lung Injury in Rats.

Authors:  Fengjun Tian; Yiling Ling; Yuqin Chen; Zhiyong Wang
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 5.  Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways.

Authors:  Jie Wang A; Jingjing Zhang; Mengjie Xiao; Shudong Wang; Jie Wang B; Yuanfang Guo; Yufeng Tang; Junlian Gu
Journal:  Cell Mol Life Sci       Date:  2021-01-13       Impact factor: 9.261

6.  Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes.

Authors:  Mi-Hua Liu; Jian Shan; Jian Li; Yuan Zhang; Xiao-Long Lin
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447

Review 7.  Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases.

Authors:  Bryan T Hackfort; Paras K Mishra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-22       Impact factor: 4.733

8.  MicroRNA expression profiling involved in doxorubicin-induced cardiotoxicity using high-throughput deep-sequencing analysis.

Authors:  Ying Chen; Yingjie Xu; Zhoufeng Deng; Yin Wang; Ying Zheng; Weihua Jiang; Li Jiang
Journal:  Oncol Lett       Date:  2021-05-26       Impact factor: 2.967

9.  Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms.

Authors:  Athanasia Chatzianastasiou; Sofia-Iris Bibli; Ioanna Andreadou; Panagiotis Efentakis; Nina Kaludercic; Mark E Wood; Matthew Whiteman; Fabio Di Lisa; Andreas Daiber; Vangelis G Manolopoulos; Csaba Szabó; Andreas Papapetropoulos
Journal:  J Pharmacol Exp Ther       Date:  2016-06-24       Impact factor: 4.030

Review 10.  Chemotherapy: a double-edged sword in cancer treatment.

Authors:  Nafiseh Behranvand; Farzad Nasri; Reza Zolfaghari Emameh; Pouria Khani; Asieh Hosseini; Johan Garssen; Reza Falak
Journal:  Cancer Immunol Immunother       Date:  2021-08-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.